Blog

10 Remote Patient Monitoring Companies Shaping the Global mHealth Market

Healthcare & Pharmaceuticals · Market Insight

Global mHealth Market to Reach USD 801.22 Billion by 2040: Inside the 10 Companies Powering the Remote-Care Revolution

Mobile health has become core clinical infrastructure. Here is how big the market is, how it is segmented, and the connected-care companies building the rails beneath it.

By Global Data Route Analytics (GDRA)  |  Healthcare & Pharmaceuticals Research

Mobile health, or mHealth, refers to the use of smartphones, tablets, wearables, and connected medical devices paired with software and services to deliver, support, and enhance healthcare. Over the last decade it has evolved from simple wellness tracking into a clinical backbone that supports remote patient monitoring (RPM), teleconsultation, chronic disease management, and continuous connected care. According to Global Data Route Analytics (GDRA), this transformation is reflected in strong, sustained market growth through 2040.

Below, we break down GDRA's market sizing and segmentation for the Global mHealth Market, then go company-by-company through ten of the most active remote patient monitoring and connected-care players — what each does, its impact on the market, a short analysis, and the opportunity it represents, with independent external sources for verification.

How Big Is the Global mHealth Market?

Per GDRA's research, the Global mHealth Market was valued at USD 120,852.77 million in 2025 and is projected to reach USD 801,216.49 million by 2040, expanding at a compound annual growth rate (CAGR) of 13.44% from 2025 to 2040. This growth is driven by increasing smartphone penetration, rising adoption of mobile healthcare applications, expanding use of connected medical devices, and growing demand for remote patient monitoring and virtual healthcare services.

$120.85 Bn 2025 Market Value $801.22 Bn 2040 Projection 13.44% CAGR (2025–2040)

The GDRA report provides a detailed analysis by offering, application type, connected device form factor, monitoring function, clinical use case, therapeutic area, user, customer type, care setting, deployment model, revenue model, connectivity technology, and region — making it one of the most granular views of the mHealth landscape available.

Go Deeper Than the Blog

Access GDRA's full Global mHealth Market Research Report (2020–2040) — complete sizing, segment-level forecasts, competitive landscape, and regional breakdowns across 997 pages.

Download Free Sample Submit an Inquiry Request a Discount

Market Segmentation

GDRA segments the Global mHealth Market across multiple dimensions. The primary segmentation axes are summarized below:

Segment Categories
By Offering mHealth Applications and Software; Connected mHealth Devices; mHealth Services
By Application Type Medical and Clinical Applications; Wellness and Preventive Health Applications
By Connected Device Form Factor Wearable Devices; Handheld and Portable Devices; Smartphone- and Tablet-Connected Accessories; Connected Home Health Devices; Connected Medication Management Devices; Connected Implantable Devices
By Monitoring Function Single-Parameter Monitoring; Multi-Parameter Monitoring
By Deployment Model Cloud-Based; On-Device and Edge-Based; On-Premises Enterprise; Hybrid mHealth Solutions
By Connectivity Technology Bluetooth / BLE; Cellular (4G/LTE, 5G, LTE-M, NB-IoT); Wi-Fi; NFC; Low-Power Wide-Area Networks; Satellite; Multi-Connectivity
By Region North America; Europe; Asia Pacific; Latin America; Middle East and Africa

Beyond these, the report also breaks the market down by primary clinical use case, disease and therapeutic area, primary user, customer type, care setting, and revenue model — providing a comprehensive framework for understanding where value is created across the mHealth ecosystem. The remote patient monitoring function sits at the center of this framework — and it is where the ten companies profiled below compete.

10 Companies Powering the mHealth & Remote-Care Market

Each profile below covers what the company does, its impact on the mHealth market, a short analysis, and the opportunity it represents — with independent, external sources for verification.

01HealthArc

RPM · CCM · RTM Software

What it does: HealthArc is a cloud-based, HIPAA-compliant digital health platform specializing in Remote Patient Monitoring (RPM), Chronic Care Management (CCM), and Remote Therapeutic Monitoring (RTM). Its platform automatically collects vitals — blood pressure, weight, blood glucose, oxygen saturation, ECG — via connected devices, layers an AI dashboard that flags abnormal trends, and offers bi-directional integration with major EHRs such as Epic, Cerner, and Athenahealth, plus a fully managed clinical-staffing service model.

Impact on the market: HealthArc sits squarely in the mHealth Services and remote monitoring segments, and its coverage of 20+ EHRs and 40+ devices makes it an interoperability hub — the kind of connected, interoperable platform driving mHealth adoption among providers.

Analysis & opportunity: By automating CMS RPM CPT codes and promising a first-billed patient within 30 days, HealthArc lowers the operational barrier for smaller practices — the long tail of providers that will drive volume growth. Its hybrid model (self-serve software plus managed clinical staff) lets it scale across practice sizes.

Sources: healtharc.io · RPM software overview

02CareSimple

Turnkey RPM Infrastructure

What it does: CareSimple provides full-stack RPM infrastructure — FDA-cleared cellular devices, connectivity across AT&T, Verizon and T-Mobile, software, EHR integration, automated billing, and an optional clinical team — under one accountable vendor. It is an Epic Toolbox–designated app and also integrates with Oracle Health, Meditech, athenahealth, NextGen, and eClinicalWorks.

Impact on the market: Founded in 2009 and employee-owned, CareSimple reports its mHealth apps have been downloaded more than 4 million times. Partnerships with large health systems and a collaboration to bring turnkey RPM to health plans give it payer-side reach across the customer-type spectrum. CareSimple is one of the remote patient monitoring and care-management companies profiled in the GDRA report.

Analysis & opportunity: CareSimple's "no app required" cellular-first approach targets the adherence problem that undermines many RPM programs. Its flexibility — clinics keep clinical control while delegating operations — makes it attractive to large health systems seeking to scale without ceding the patient relationship.

Sources: caresimple.com · About CareSimple

03Accuhealth

Full-Service RPM Platform

What it does: Accuhealth delivers turnkey RPM through its proprietary, SOC 2-certified, HIPAA-compliant platform. It supplies cellular-enabled (4G) blood pressure monitors, glucometers, pulse oximeters, heart-rate monitors and scales — with true data-field EHR integration rather than PDF scans, and an automatic, timestamped clinical audit trail.

Impact on the market: Accuhealth has been recognized among fast-growing technology companies and as an RPM industry leader, with a platform designed to sustain high patient volumes per clinic — supporting the scalability that mass-market mHealth adoption requires.

Analysis & opportunity: By assuming upfront device costs and offering no-contract, participation-based billing, Accuhealth removes financial risk for providers — a scalability lever. Its compliance-first audit architecture is a differentiator as reimbursement scrutiny of RPM billing intensifies.

Sources: accuhealthlabs.com · accuhealth.tech

04Health Recovery Solutions (HRS)

Enterprise Telehealth & RPM

What it does: HRS offers advanced RPM and telehealth through its PatientConnect suite — supporting 90+ conditions with biometric monitoring, virtual visits, symptom screening, and medication management, plus tablet-based, BYOD (bring-your-own-device), and caregiver-inclusive options. It pairs technology with clinical advisory, logistics, reimbursement, and marketing support as a single-source partner.

Impact on the market: HRS reports partnerships with 400+ U.S. health systems and 400,000+ patients, and was named Best in KLAS for Remote Patient Monitoring for three consecutive years (2020–2022). It is one of the remote patient monitoring and care-management companies profiled in the GDRA report, and documented client outcomes include readmission reductions of up to 75% among targeted high-risk populations.

Analysis & opportunity: HRS targets the enterprise tier — hospitals, health systems, home-health, and hospice — where Hospital-at-Home programs are expanding. Its breadth across the care continuum and reimbursement expertise position it to capture value-based-care spending as payers reward outcome improvements.

Sources: healthrecoverysolutions.com · Solutions overview

05Tenovi

Device & Data-Aggregation Platform

What it does: Tenovi is a data-aggregation and automation platform connecting medical-device manufacturers with RPM companies. Its award-winning plug-and-play Cellular Gateway links 60+ Bluetooth and cellular devices, transmitting readings to the Tenovi Cloud and onward to any RPM software platform through a single API — with no apps, syncing, or Wi-Fi required, and an LED reminder system to boost measurement adherence.

Impact on the market: Tenovi reports powering programs for 300+ RPM companies with 100,000+ devices deployed, partnering with device makers including A&D Medical, Omron, Transtek, Trividia, Welch Allyn and Nonin. It supplies the connected-device and connectivity backbone that the mHealth "Connected Devices" segment depends on.

Analysis & opportunity: Tenovi occupies the "picks-and-shovels" layer of the mHealth market — supplying hardware and connectivity rather than competing for end clinics. As RPM programs proliferate, an interoperable one-API model scales efficiently and benefits from every new entrant.

Sources: tenovi.com · RPM devices & gateway

06TimeDoc Health

Virtual Care Management · CCM · RPM · BHI

What it does: TimeDoc Health provides EHR-integrated, tech-enabled virtual care management spanning Chronic Care Management (CCM), Remote Patient Monitoring (RPM), Advanced Primary Care Management (APCM), and Behavioral Health Integration (BHI) — all in one platform. It combines software with clinical staff augmentation, letting practices fully outsource monthly care coordination or fill staffing gaps.

Impact on the market: TimeDoc reports clients see a 23% increase in RPM adherence when RPM runs inside a full virtual-care-management program. With specialized workflows for cardiology, endocrinology, nephrology and primary care, it targets the CCM-first model that pulls RPM along with it — expanding the mHealth Services segment.

Analysis & opportunity: By bundling RPM with CCM, APCM and BHI, TimeDoc captures more of the reimbursement stack per patient — increasing revenue-per-enrollee. Its "technology plus human connection" approach addresses the engagement gap that pure-software vendors struggle with.

Sources: timedochealth.com · Virtual care management

07Prevounce

Remote Care + AI Insights

What it does: Prevounce Health offers an all-in-one, HIPAA-compliant remote care management platform covering RPM, CCM, APCM, Annual Wellness Visits, and preventive services, paired with pre-configured cellular devices and optional clinical staffing. Its "AI Insights" feature applies generative AI to analyze RPM readings and care notes, surfacing care summaries and actionable recommendations.

Impact on the market: Prevounce enables provider setup within 48 hours and uses a billable-patient-only pricing model with no upfront platform fees — reducing adoption friction, especially for rural and community health providers. Its AI layer reflects the cloud and edge deployment models and AI-driven direction of the mHealth market.

Analysis & opportunity: Prevounce's breadth across preventive and chronic care, plus early integration of clinically validated AI recommendations, positions it to move up the value chain from data capture to decision support — where higher-margin opportunities lie.

Sources: prevounce.com · Platform software

08CoachCare

RPM · CCM · Patient Engagement

What it does: CoachCare provides a virtual-health and RPM platform combining a branded patient mobile app, provider dashboard, connected devices (smart scale, BP cuff, glucometer, pulse oximeter), live video, messaging, and automated alerts. Its CareConnect layer offers deep bi-directional EHR integrations and supports a broad device marketplace across RPM, CGM and RTM.

Impact on the market: CoachCare emphasizes program economics — reporting typical RPM clients see roughly 4.2x annual ROI — and can brand a custom RPM app and launch programs in as little as two weeks. It is one of the remote patient monitoring and care-management companies profiled in the GDRA report.

Analysis & opportunity: CoachCare's strength is patient engagement and accountability, extending naturally from wellness and weight-management coaching into clinical RPM. Its ROI-forward positioning appeals to independent providers evaluating whether to launch programs at all — expanding the total addressable market.

Sources: coachcare.com · RPM software

09BioIntelliSense

Medical-Grade Continuous Wearables

What it does: BioIntelliSense is a continuous health-monitoring and clinical-intelligence company. Its FDA-cleared BioButton wearable continuously captures 20+ vital signs and biometrics, feeding a medical-grade Data-as-a-Service (DaaS) platform (BioHub gateways, BioMobile app, BioCloud data services) and the BioDashboard clinical-intelligence system that uses exception management to reduce alert fatigue.

Impact on the market: BioIntelliSense pushes mHealth from episodic spot-checks toward continuous, medical-grade multi-parameter monitoring — spanning inpatient, ED observation, hospital-at-home, and post-discharge care. It is one of the connected devices, wearables and medical monitoring companies profiled in the GDRA report, with peer-reviewed research and FDA clearance for its Multi-Patient wearable and BioDashboard system.

Analysis & opportunity: As the mHealth market matures, the frontier moves from intermittent readings to continuous physiological trending. BioIntelliSense's clinically validated, "scale care without scaling costs" proposition targets the acute-to-home continuum — a high-value, high-acuity slice of the market.

Sources: biointellisense.com · FDA clearance (Medical Device Network)

10Cadence

AI-Enabled Chronic Disease Management

What it does: Cadence delivers RPM and responsive virtual care for chronic conditions — heart failure, type 2 diabetes, hypertension, and COPD — combining a technology platform, its own Medical Group, and 24/7 clinical staff that act as an extension of the ordering physician. Its Clinical Intelligence automates the high-volume work of chronic care: monitoring patients, surfacing risks, and coordinating action.

Impact on the market: Cadence reports partnerships with 20+ leading health systems and a population exceeding 90,000 patients. It is one of the remote patient monitoring and care-management companies profiled in the GDRA report, with published outcomes including a 61% reduction in heart-failure readmissions and up to a 52% reduction in total cost of care for heart-failure patients.

Analysis & opportunity: Cadence targets the single largest cost driver in healthcare — chronic disease among aging populations. Its outcomes-and-cost dual proof point aligns squarely with value-based care, making it a template for how AI-enabled RPM can be both clinically effective and financially scalable.

Sources: cadence.care · 2023 Outcomes Report

What This Tells Us About the mHealth Market

Taken together, these ten companies map onto the structure GDRA describes. Tenovi supplies the device-and-connectivity backbone; HealthArc, CareSimple, Accuhealth, TimeDoc, Prevounce and CoachCare build the software-and-services layer for clinics and health systems; BioIntelliSense pushes the clinical frontier into continuous medical-grade wearables; and Cadence and HRS operate at the enterprise, outcomes-and-reimbursement tier where value-based care is won or lost.

Three themes recur across every profile — and each reinforces GDRA's growth thesis. First, interoperability: deep EHR integration is now table stakes. Second, AI and clinical intelligence: the winners convert raw vitals into a prioritized action list, tackling alert fatigue and clinician burnout. Third, reimbursement engineering: mastery of CMS CPT codes turns remote care from a cost center into a revenue stream, which is what ultimately fuels adoption at scale.

The bottom line: GDRA's projection of a market reaching USD 801.22 billion by 2040 at a 13.44% CAGR is a bet that continuous, connected, AI-assisted care becomes the default operating model for managing chronic disease — and the companies above are already building the infrastructure to make that happen.

Get the Full Global mHealth Market Report

Segment forecasts, competitive benchmarking, regional analysis, and the complete company landscape — from Global Data Route Analytics.

Download Free Sample Submit an Inquiry Request a Discount

Sources & Further Reading

Primary market data: Global Data Route Analytics — Global mHealth Market Research Report (2020–2040).

Market sizing (USD 120,852.77 million in 2025; USD 801,216.49 million by 2040; 13.44% CAGR) and segmentation are sourced from the Global Data Route Analytics Global mHealth Market Research Report (2020–2040). Company descriptions and outcome figures are drawn from each company's own published materials and referenced third-party coverage. This article is for informational purposes and does not constitute investment advice. © Global Data Route Analytics (GDRA).